EcoDrugPlus

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSTRUG00000026188
Gene Symbol: ALOX5AP
3 Cross references
199 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSTRUG00000026813
Gene Symbol: ALOX5AP
3 Cross references
199 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSTRUG00000016314
Gene Symbol: AVPR1A
4 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSTRUG00000006025
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSTRUG00000000643
Gene Symbol: AVPR2
1 Cross references
148 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSTRUG00000000936
Gene Symbol: LOC101072043
3 Cross references
190 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSTRUG00000013307
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSTRUG00000014460
Gene Symbol: LOC101076892
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSTRUG00000030575
Gene Symbol: LOC101076691
4 Cross references
226 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSTRUG00000009069
Gene Symbol: LOC101072937
3 Cross references
195 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSTRUG00000007818
Gene Symbol: BACE1
4 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSTRUG00000013511
Gene Symbol: BDKRB2
1 Cross references
285 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).